Barbirou, Mouadh
Miller, Amanda A.
Gafni, Erik
Mezlini, Amel
Zidi, Asma
Boley, Nathan
Tonellato, Peter J.
Article History
Received: 3 September 2021
Accepted: 6 May 2022
First Online: 19 May 2022
Competing interests
: Erik Gafni and Nathan Boley are employees of Ravel Biotechnology Startup. The remaining authors have no conflict.